Inventaire - your friends and communities are your best library - Inventaire

Adenoviral vectors for gene therapy

published in: Molecular Biotechnology

date of publication: 2007-05-01

main subject: gene therapy, Adenoviridae

Cites articles 60

Date

Title

Authors

2006-04-16

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.

Jaap Goudsmit, Peter Abbink, Dan H. Barouch, Darci A Gorgone, Michelle A Lifton, Angelique Lemckert, Keith G Mansfield, Menzo Havenga, Angela A L Carville, Lennart Holterman, Anjali Nanda, Bonnie A Ewald
2006-08-01

INGN 201 (Advexin): adenoviral p53 gene therapy for cancer
2006-01-01

Adenovirus p53 gene therapy
2006-10-01

Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity

Paul Quax, Jaap Goudsmit, Dan H. Barouch, Angelique Lemckert
2006-08-01

Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis
2006-03-31

Adenovirus type 5 interactions with human blood cells may compromise systemic delivery

Kerry D Fisher
2006-07-01

Preclinical safety and biodistribution of adenovirus-based cancer vaccines after intradermal delivery
2005-06

Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity
2005-09-01

Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers
2005-09-01

Gendicine: the first commercial gene therapy product

James Wilson
2005-12-13

Chimpanzee adenovirus vaccine protects against Zaire Ebola virus

James Wilson, Heinz Feldmann, Gary P. Kobinger, Friederike Feldmann
2004-06-01

Increased regional function and perfusion after intracoronary delivery of adenovirus encoding fibroblast growth factor 4: report of preclinical data
2003-08-01

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

Thomas W Geisbert, Gary Nabel, Peter B. Jahrling, Zhi-Yong Yang, Mario Roederer, Richard A Koup, Nancy Sullivan, Joan B Geisbert
2003-11-01

Genetically targeted adenovirus vector directed to CD40-expressing cells

David T. Curiel
2002-01-01

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

David C. Montefiori, Norman L. Letvin, Michelle A Lifton, Jörn E. Schmitz, Georgia R. Krivulka, John W Shiver, Helen Perry, Sheri Dubey, Danilo R Casimiro
2002-02-01

Targeting of adenovirus vectors to tumor cells does not enable efficient transduction of breast cancer metastases
2002-09-01

Dual targeting of adenoviral vectors at the levels of transduction and transcription enhances the specificity of gene expression in cancer cells

David T. Curiel
2002-02-01

Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes

Hiroyuki Mizuguchi
2002-01-01

Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells

Akseli Hemminki, David T. Curiel, Anna Kanerva
2002-09-01

The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells

Kurt R. Zinn, David T. Curiel
2002-05-01

Targeted adenoviral vectors.
2001-05-01

Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin

David T. Curiel
2001-05-01

The promise and potential hazards of adenovirus gene therapy
2000-05-01

Genetic targeting of adenoviral vectors
2000-08-01

Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells

David T. Curiel
2000-08-01

A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial

David T. Curiel
2000-10-01

Production of first generation adenovirus vectors: a review
2000-01-01

A cell line for high-yield production of E1-deleted adenovirus vectors without the emergence of replication-competent virus
1999-06-01

Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector

David T. Curiel
1999-12-01

Gene transfer by adenovectors
1999-09

Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers
1999-03-01

Coxsackievirus and adenovirus receptor cytoplasmic and transmembrane domains are not essential for coxsackievirus and adenovirus infection

Article - wd:Q36935134

Welcome to Inventaire

the library of your friends and communities

you are offline